Searched for
BLADDER DRUG
India raises price cap on cancer drugs to tackle shortageIndia's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused b...- Cancer drug prices raised 50% as NPPA acts on shortage concernsIndia's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...
- Indian cancer patients battle shortage of key drugs as platinum costs surgeCancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...
- In 1937, a chemistry student tasted something sweet on a cigarette, and this led to a sweetener that changed diet foods industryA lab accident in 1937 led to the discovery of cyclamate, an artificial sweetener. It quickly became popular for low-calorie products. Late...
- US Stocks: ImmunityBio shares drop 20% on FDA warning letter over cancer therapy claims in adShares of ImmunityBio fell 20% on Tuesday after the U.S. Food and Drug Administration issued a warning letter that said a television advert...
- Matthew Perry died of a ketamine overdose; Elon Musk is reportedly a frequent user - what does ketamine do to the body?Recent attention has been drawn to ketamine's risks and increasing use, highlighted by Matthew Perry's death and Elon Musk's reported heavy...
- Zydus Lifesciences launches generic drug for overactive bladder in US marketZydus is among the first suppliers to launch the generic version of Mirabegron extended-release tablets (USP 25 mg) in the US market. The c...
- SII manufactured BCG vaccine gets export nod to treat bladder cancerThe Serum Institute of India has been granted permission to export its BCG vaccine to Canada for the treatment of bladder cancer, following...
- Lupin gets USFDA nod for generic medicationThe company has received approval from the US Food and Drug Administration to market Fesoterodine Fumarate extended-release tablets in stre...
- Alembic Pharma gets tentative USFDA nod for fesoterodine fumarate extended-release tabletsThe approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) for fesoterodine fumarate extende...
- Zydus Cadila gets USFDA nod for overactive bladder treatment drugThe company has received final approval from the United States Food and Drug Administration (USFDA) to market Solifenacin Succinate tablets...
- Granules India gets USFDA nod for overactive bladder treatment capsule"The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application filed by Granules Pharmaceuticals, Inc, a wh...
- Alembic Pharmaceuticals gets USFDA go-ahead for bladder drugAccording to IMS December 2016 data, Darifenacin extended release tablets had an estimated market size of USD 64 million.
- USFDA gives nod to Zydus Cadila's overactive bladder tabletsThe drug is used to take care of an overactive bladder and urinary incontinence and will be produced at the group's formulation manufacturi...
- Glenmark Pharma's overactive bladder drug gets USFDA nodAccording to IMS Health April 2017 sales data, the market for Vesicare tablets, 5 mg and 10 mg, saw annual sales of approximately USD 1.1 b...
- Some drugs, banned in other countries, allowed in India: GovernmentMinister of State for Health Faggan Singh Kulaste in a written reply said that the drugs which have been allowed are nimesulide, analgin an...
- Common cold medicine can prevent bladder cancer riskBladder cancer is the seventh most common cancer in males worldwide.
- Cheap drug for common cold can stop spread of cancerTokyo, Oct 18 (IANS) A non-steroid, anti-inflammatory drug used for treating common cold has the potential to suppress the spread of bladde...
- Diabetes drug may increase bladder cancer risk, says studyPioglitazone belongs to a class of drugs called thiazolidinediones that help to control blood sugar levels in patients with type 2 diabetes.
- Health ministry to review ban on Pioglitazone tomorrowIn the wake of opposition from industry and medical fraternity to the ban on anti-diabetes drug Pioglitazone, DTAB will review the decision...
Load More
